<DOC>
	<DOCNO>NCT02241876</DOCNO>
	<brief_summary>Head neck cancer correspond tumor locate upper aerodigestive tract , oral cavity , pharynx larynx . The effective treatment consist high dose cisplatin chemotherapy radiotherapy , however , use limit due toxicity cause mainly oxidative stress . The objective study evaluate use n-acetylcysteine attenuate cisplatin-induced toxicity oxidative stress head neck cancer patient . This randomized double-blind placebo-controlled clinical trial consecutive sampling conduct Oncology Department Clinic Hospital / University Campinas ( UNICAMP ) . Head neck cancer patient begin cisplatin antineoplastic treatment ( 80-100mg/m2 day 1 , 22 43 ) concurrent radiotherapy include research . They study 2 group ( n-acetylcysteine placebo ) . All patient evaluate relation cisplatin induce hematologic gastrointestinal disorder , nephrotoxicity , ototoxicity , hepatotoxicity ; plasmatic cellular oxidative stress ; quality life ; pharmacoeconomic evaluation . Results statistically analyse use Chi-square , Fisher , Mann-Whitney , ANOVA repeat measure test ( p &lt; 0.05 . )</brief_summary>
	<brief_title>THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>head neck cancer anticancer treatment cisplatin ( 80 100 mg/mÂ² ) plus radiotherapy patient without previous treatment head neck cancer ( surgery , chemotherapy radiotherapy ) severe psychiatric disease impossibility verbal communication without caregiver companion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>